{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:37:37Z","timestamp":1770910657643,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2010,9,19]],"date-time":"2010-09-19T00:00:00Z","timestamp":1284854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1245\/s10434-010-1262-2","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T19:46:00Z","timestamp":1284752760000},"page":"368-377","source":"Crossref","is-referenced-by-count":15,"title":["Long-Term Follow-up Study of a Prospective Multicenter Sentinel Node Trial: Molecular Detection of Breast Cancer Sentinel Node Metastases"],"prefix":"10.1245","volume":"17","author":[{"name":"for the ECU\/AAMC Sentinel Node Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn Mary","family":"Verbanac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher Justus","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann Elizabeth","family":"Mannie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin F.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Rosman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"Tafra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,19]]},"reference":[{"key":"1262_CR1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000658-200101000-00009","volume":"233","author":"L Tafra","year":"2001","unstructured":"Tafra L, Lannin DR, Swanson MS, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg. 2001;233:51\u20139.","journal-title":"Ann Surg"},{"key":"1262_CR2","first-page":"4581","volume":"58","author":"CJ Min","year":"1998","unstructured":"Min CJ, Tafra L, Verbanac KM. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes. Cancer Res. 1998;58:4581\u20134.","journal-title":"Cancer Res"},{"key":"1262_CR3","first-page":"860","volume":"56","author":"MA Watson","year":"1996","unstructured":"Watson MA, Fleming TP. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res. 1996;56:860\u20135.","journal-title":"Cancer Res"},{"key":"1262_CR4","first-page":"3028","volume":"59","author":"MA Watson","year":"1999","unstructured":"Watson MA, Dintzis S, Darrow CM, et al. Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res. 1999;59:3028\u201331.","journal-title":"Cancer Res"},{"key":"1262_CR5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1749-6632.2000.tb05521.x","volume":"923","author":"TP Fleming","year":"2000","unstructured":"Fleming TP, Watson MA. Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Ann N Y Acad Sci. 2000;923:78\u201389.","journal-title":"Ann N Y Acad Sci"},{"key":"1262_CR6","doi-asserted-by":"crossref","first-page":"9516","DOI":"10.1200\/jco.2004.22.14_suppl.9516","volume":"22","author":"KM Verbanac","year":"2004","unstructured":"Verbanac KM, Min J, Mannie AE, et al. Clinical significance of PCR-detected metastases in sentinel nodes of breast cancer patients: an interim report. J Clin Oncol. 2004;22:9516","journal-title":"J Clin Oncol"},{"key":"1262_CR7","first-page":"S12","volume":"88","author":"KM Verbanac","year":"2004","unstructured":"Verbanac KM, Min CJ, Mannie A, et al. Multimarker quantitative RT-PCR detects nodal metastases in recurrent patients enrolled in multicenter sentinel node trial. Breast Cancer Res Treat. 2004;88:S12\u20133.","journal-title":"Breast Cancer Res Treat"},{"key":"1262_CR8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1525-1578(10)60561-2","volume":"7","author":"J Backus","year":"2005","unstructured":"Backus J, Laughlin T, Wang Y, et al. Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis. J Mol Diagn. 2005;7:327\u201336.","journal-title":"J Mol Diagn"},{"key":"1262_CR9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jamcollsurg.2008.10.036","volume":"208","author":"J Reed","year":"2009","unstructured":"Reed J, Rosman M, Verbanac KM, et al. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University\/Anne Arundel Medical Center Sentinel Node Multicenter Study. J Am Coll Surg. 2009;208:333\u201340.","journal-title":"J Am Coll Surg"},{"key":"1262_CR10","first-page":"S126","volume":"76","author":"KM Verbanac","year":"2002","unstructured":"Verbanac KM, Mannie A, Min CJ, et al. RT-PCR detection of breast cancer metastases in sentinel lymph nodes of breast cancer patients. Breast Cancer Res Treat. 2002;76:S126.","journal-title":"Breast Cancer Res Treat"},{"key":"1262_CR11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(98)11104-2","volume":"354","author":"RJ Cote","year":"1999","unstructured":"Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet. 1999;354:896\u2013900.","journal-title":"Lancet"},{"key":"1262_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3322\/canjclin.56.1.37","volume":"56","author":"SE Singletary","year":"2006","unstructured":"Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC staging manual. CA Cancer J Clin. 2006;56:37\u201347.","journal-title":"CA Cancer J Clin"},{"key":"1262_CR13","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cncr.11865","volume":"98","author":"SE Singletary","year":"2003","unstructured":"Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer staging manual. Cancer. 2003;98:2740\u20131.","journal-title":"Cancer"},{"key":"1262_CR14","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1586\/14737140.7.11.1665","volume":"7","author":"S Shivers","year":"2007","unstructured":"Shivers S, Jakub J, Pendas S, et al. Molecular staging for patients with malignant melanoma. Expert Rev Anticancer Ther. 2007;7:1665\u201374.","journal-title":"Expert Rev Anticancer Ther"},{"key":"1262_CR15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejso.2006.09.013","volume":"33","author":"P Gimbergues","year":"2007","unstructured":"Gimbergues P, Dauplat MM, Cayre A, et al. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category. Eur J Surg Oncol. 2007;33:16\u201322.","journal-title":"Eur J Surg Oncol"},{"key":"1262_CR16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/(SICI)1097-0215(19981218)79:6<645::AID-IJC16>3.0.CO;2-R","volume":"79","author":"PJ Bostick","year":"1998","unstructured":"Bostick PJ, Huynh KT, Sarantou T, et al. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR. Int J Cancer. 1998;79:645\u201351.","journal-title":"Int J Cancer"},{"key":"1262_CR17","first-page":"4176","volume":"6","author":"N Masuda","year":"2000","unstructured":"Masuda N, Tamaki Y, Sakita I, et al. Clinical significance of micrometastases in axillary lymph nodes assessed by reverse transcription-polymerase chain reaction in breast cancer patients. Clin Cancer Res. 2000;6:4176\u201385.","journal-title":"Clin Cancer Res"},{"key":"1262_CR18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/SLA.0b013e318157d22b","volume":"247","author":"G Viale","year":"2008","unstructured":"Viale G, Dell\u2019Orto P, Biasi MO, et al. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg. 2008;247:136\u201342.","journal-title":"Ann Surg"},{"key":"1262_CR19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1245\/ASO.2003.01.010","volume":"10","author":"M Sakaguchi","year":"2003","unstructured":"Sakaguchi M, Virmani A, Dudak MW, et al. Clinical relevance of reverse-transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer. Ann Surg Oncol. 2003;10:117\u201325.","journal-title":"Ann Surg Oncol"},{"key":"1262_CR20","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.surg.2005.07.001","volume":"138","author":"K Mikhitarian","year":"2005","unstructured":"Mikhitarian K, Martin RH, Mitas M, et al. Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study. Surgery. 2005;138:474\u201381.","journal-title":"Surgery"},{"key":"1262_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07357900701784238","volume":"26","author":"J Peppercorn","year":"2008","unstructured":"Peppercorn J, Perou CM, Carey LA. Molecular subtypes in breast cancer evaluation and management: divide and conquer. Cancer Invest. 2008;26:1\u201310.","journal-title":"Cancer Invest"},{"issue":"Suppl 3","key":"1262_CR22","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/S0960-9776(09)70290-5","volume":"18","author":"KS Albain","year":"2009","unstructured":"Albain KS, Paik S, van\u2019t Veer L. Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays. Breast. 2009;18(Suppl 3):S141\u20135.","journal-title":"Breast"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-010-1262-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-010-1262-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-010-1262-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T11:38:46Z","timestamp":1572953926000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-010-1262-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,19]]},"references-count":22,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["1262"],"URL":"https:\/\/doi.org\/10.1245\/s10434-010-1262-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,19]]}}}